Just bought in. long term hold for me. I hope we see 8 before 3 Ameen
Bought IMGN- $6.70 yesterday. Great potential here with their Pipeline and Approved product. Excellent BuyOut potential too. My other stocks, AVEO recent Approved First line Renal Cell Cancer drug in the EU, major milestone due. ACRX Approval date Oct 12 for a very unique sublingual pain med, sufentanil.
Great pipeline, 3 P3 trials going, 4 P2 and 11 P1's and an Approved Product. Big Pharma could really beef up their pipeline if they bought IMGN.
Looking at the 1 month chart, support is at 6.4. The 5 day chart confirms a drop off as 6.4 approached. Next support is $6 range. If that falls, it'll be $5.5 ish. The 6 month chart shows support should kick in shortly around $6, so... umm good luck to us all. I currently hold no position and will enter when it looks safe.
Perhaps a short-term pull back is more likely before the next rally on IMGN? This is so frustrating trying to find trade ideas. I've subscribed to some email newsletters which helps me with new stock ideas. awe-some*sto-cks is the one i like best.
Load up next stop is 10
In the short-term IMGN does not seem to be like a good trade. Yo you should really check out awe.some*sto-cks, they seem on point with their stocks.
@Frank I think we are within 2-3 trading days of a Reversal. So at the very least Tue next week see's a Reversal. The dilution should have dropped the stock to about $6. But for some reason it only dropped from $7.55 to $ 6.75. It definitely fooled me as it seemed it move sideways. Indicators OVERSOLD.
Going to 3
Like the great Mike Tyson once said, "everyone has a plan 'til they get punched in the mouth"
Analysts on a consensus basis are expecting that the stock will reach $9.29 within the year.
Bark or Bite? What is The Street Consensus on ImmunoGen, Inc. (NASDAQ:IMGN) – Stock Press Daily
MACD crossed over, RSI, MFI, DMI are all weak while ROC has increased somewhat. Tells me this one has some more runway to drop in price. Great company, I'm a long, just reading the technical indicators.